Observational Study to Assess Transradial Access for Treatment in the Lower Extremities.
Completed · NCT04371861
Conditions: Peripheral Arterial Disease
At a glance
- Research payments reported, 2025
- $102,000
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 120
About the trial
- Sponsor
- Terumo Medical Corporation
- Tested
- Peripheral Artery Treatment (device)
- Dates
- Started 2020-06-29; completion 2022-06-30
- Results posted
- Yes
This study is designed to collect data on the complication rates and procedural success of using a transradial access approach to treat peripheral lesions in the lower extremities of a real world population.
From ClinicalTrials.gov, last updated 2026-10-22. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Terumo Medical Corporation reported $102,000 in research payments for this study in 2025 (3 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Baylor Scott & White Research $102,000
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.